Our ability to distinguish cancer drivers and passengers and identify cancer-relevant signaling networks using our cutting-edge novel gene interaction approach is of high-relevance to the CTD2 mission, and the goal of developing rational combination therapies that may improve outcomes for genetically-defined subsets of cancer patients. This is our unwavering mission...
The goal of the Cancer Target Discovery and Development (CTD²) Network is to accelerate the translation of genomic discoveries into new cancer treatments through innovative research. Our team brings together a critical range of expertise in cancer biology, functional genomics, and systems biology as well as a unique next generation CRISPR screening strategies that greatly increase our ability to monitor the precise phenotypic consequences of perturbing combinations of genes.